The aim of these studies is to determine the maximum tolerated single dose of a monoclonal antibody directed against melanoma cells and linked with ricin a chain. A single dose escalation study protocol with three patients at each dose is being followed. Patients are evaluated to toxicity and tumor response.
Showing the most recent 10 out of 1065 publications